G
Market Data
$2.41+$0.19 (+8.56%)
GRCE · Last trade
Prev Close
$2.22
Range (29d)
$2.22 – $2.53
Recent Filings
- 8-K6.8 MBGrace Therapeutics, Inc.Jun 18, 8:15 AM ET·0001140361-26-025669
- 8-K333.3 KBGrace Therapeutics, Inc.Jun 18, 8:01 AM ET·0001140361-26-025667
- 10-K15.2 MBGrace Therapeutics, Inc.Jun 18, 7:31 AM ET·0001140361-26-025662
- 8-K245.5 KBGrace Therapeutics, Inc.Jun 5, 4:09 PM ET·0001140361-26-024269
- 8-K7.3 MBGrace Therapeutics, Inc.Apr 27, 7:08 AM ET·0001140361-26-016834
- 8-K190.6 KBGrace Therapeutics, Inc.Apr 23, 2:36 PM ET·0001140361-26-016324
- 8-K345.3 KBGrace Therapeutics, Inc.Feb 12, 8:01 AM ET·0001140361-26-004927
- 10-Q8.0 MBGrace Therapeutics, Inc.Feb 12, 7:31 AM ET·0001140361-26-004924
- 8-K337.4 KBGrace Therapeutics, Inc.Jan 12, 5:00 PM ET·0001140361-26-000995
- 10-Q/A215.9 KBGrace Therapeutics, Inc.Nov 17, 4:22 PM ET·0001140361-25-042491
Insiders
10- ADAR1 Capital Management, LLC10% Owner
- ADAR1 Partners, LP10% Owner
- Boily Jean-FrancoisVICE-PRESIDENT, FINANCE
- Canan JohnDirector
- Carter Roderick NoelDirector
- D'Alvise JanelleDirector, PRESIDENT & CEO
- D'Andrea CarrieVP Clinical Operations
- DAVIS A BRIANDirector
- DelAversano Robert JPrincipal Financial Officer
- Derby MichaelDirector
Tickers
Addresses
business
103 CARNEGIE CENTER SUITE 300
PRINCETON, NJ, 08540
mailing
103 CARNEGIE CENTER SUITE 300
PRINCETON, NJ, 08540
Former Names
- Acasti Pharma Inc.2024-10-25